Tamai, T., Kumagai, K., Sakae, H., Onishi, H., Tabu, K., Tabu, E., . . . Ido, A. (2017). Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control? Mol Clin Oncol.
Citación estilo ChicagoTamai, Tsutomu, et al. "Early Sorafenib Induction After Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Can Sorafenib After TACE Improve Loco-regional Control?" Mol Clin Oncol 2017.
Cita MLATamai, Tsutomu, et al. "Early Sorafenib Induction After Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Can Sorafenib After TACE Improve Loco-regional Control?" Mol Clin Oncol 2017.
Precaución: Estas citas no son 100% exactas.